Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
The distribution of trypsin between the protease inhibitors of human serum with and without Trasylol was studied in vitro. 1) Trypsin was preferentially bound by alpha2-macroglobulin on addition of small amounts of the enzyme to normal serum in both the presence and absence of Trasylol in a molar concentration equal to that of alpha2-macroglobulin. 2) On saturation of alpha2-macroglobulin, a considerable amount of trypsin was bound by Trasylol even when most of the serum alpha1-antitrypsin was in a free form. 3) In reaction mixtures containing small amounts of trypsin, Trasylol was identified in a free form as well as in complex with trypsin-alpha2-macroglobulin complex and to a limited extent with trypsin. 4) With larger amounts of trypsin, sufficient to saturate alpha2-macroglobulin, increasing amounts of Trasylol were bound to trypsin. The relative amount of Trasylol bound to trypsin-alpha2-macroglobulin complexes was now smaller. This was explained by a higher affinity (or binding rate) of Trasylol for trypsin than for trypsin-alpha2-macroglobulin complexes. 5) Trypsin-Trasylol complexes showed no signs of dissociation after 5 h incubation at 37 degrees C in serum.
D007611:Aprotinin; D001798:Blood Proteins; D006801:Humans; D007122:Immunoelectrophoresis; D011480:Protease Inhibitors; D014357:Trypsin; D014361:Trypsin Inhibitors / Q000097:blood
D001798:Blood Proteins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D007611:Aprotinin; D014357:Trypsin